WO2000011205A1 - Optical oxidative enzyme-based sensors - Google Patents
Optical oxidative enzyme-based sensors Download PDFInfo
- Publication number
- WO2000011205A1 WO2000011205A1 PCT/IB1999/001451 IB9901451W WO0011205A1 WO 2000011205 A1 WO2000011205 A1 WO 2000011205A1 IB 9901451 W IB9901451 W IB 9901451W WO 0011205 A1 WO0011205 A1 WO 0011205A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oxygen
- oxidative enzyme
- phenanthroline
- layer
- sensors
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/525—Multi-layer analytical elements
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/904—Oxidoreductases (1.) acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/906—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- G01N2333/98—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- G01N2333/986—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides (3.5.2), e.g. beta-lactamase (penicillinase, 3.5.2.6), creatinine amidohydrolase (creatininase, EC 3.5.2.10), N-methylhydantoinase (3.5.2.6)
Definitions
- This invention generally relates to instrumentation for sensing various blood analytes, and more particularly towards optical sensors for detecting blood components which are substrates for oxidative enzymes.
- Patent Nos. 4,680,268, 5,352,348, and 5,298,144 are disadvantageous for use in disposable applications, because they were designed to function in a multiuse format with an elaborate instrument system, and they employ expensive materials and methods of manufacture as well as requiring wet up and calibration before use.
- Disposable or "one-shot” sensors have been disclosed also, such as the colorimetric sensor set forth in U. S. Patent No. 5,208.147.
- Disposable dry reagent strips e.g., U.S. Patent Nos. 3,992,158, 4,689.309, and 5,520.883. were developed specifically for single use applications. In operation, the sample hydrates the test strip and reagents are consumed in the development of a colorimetric change based on peroxide chemistries. They can be stored dry, are ready to use on demand, and find use in "wet" blood or serum chemistry, where the strips become saturated during use.
- An advantage of these sensors is that it is possible to bring the sensor into intimate contact with a blood sample while transmitting excitation light through the transparent substrate from the "back" side of the sensor, to enable subsequent detection of the luminescent radiation emitted from the luminescent dye from the same side of the sensor.
- Such coatings or membranes are quite thin, typically l-5 ⁇ m for pH and oxygen sensors, and show an extremely rapid response.
- red blood cells will be in contact with the sensor. Since the principal of operation of optical glucose sensors is based on oxidization of available glucose in the blood sample by immobilized glucose oxidase in the sensor (i.e.. the detection of oxygen is directly correlatable to the glucose concentration), the depletion of oxygen proximate to the membrane will be high. As such, red blood cells (RBCs) in contact with the sensor will sense the low oxygen concentration at the membrane surface and respond by releasing bound oxygen, thus acting as an oxygen buffer and skewing the results obtained.
- the presently-disclosed invention relates to enzyme-based optical sensors for detecting blood components which are substrates for oxidative enzymes, the sensors advantageously employing a multiple-layer structure featuring a thin, rapidly responding, optical, oxygen sensing layer.
- the sensor comprises, in order, a) a rapidly hydrating gas-permeable cover, or spacer, layer; b) an enzymatic layer containing an oxidative enzyme also in a water and oxygen-permeable matrix; c) an oxygen sensing layer containing luminescent dye in a light-transmissive. oxygen- permeable matrix; and, preferably, d) a light-transmissive substrate.
- the oxygen sensing layer further comprises an effective amount of a particulate filler material to reduce or eliminate sample light scattering effects.
- the inventive sensors may be used to detect glucose and other enzyme-oxidizable analytes such as lactate or cholesterol.
- the sensor additionally comprises, an enzyme "cascade" system instead of a single oxidative enzyme in the enzymatic layer containing a water and oxygen-permeable matrix. These sensors may be employed to detect analytes such as creatinine. which may not be enzymatically oxidized by a single enzyme but require several enzymatic steps to generate an oxidizable analyte derivative.
- the sensors of this disclosure may be made easily using standard coating techniques known in the art.
- the sensors are adaptable for reuse, but available materials and methods allow the sensors to be disposable as well, permitting their wide use in medical and analytical applications.
- FIG. 1 is a cross-sectional view of a sensor in accordance with one embodiment of the presently disclosed invention
- FIG. 2 is a graph illustrating the linearity of fluorescence signal response to various levels of glucose in standard buffer solution for a glucose sensor as shown in Example 1;
- FIG. 3 is a graph illustrating the response of glucose sensors made as shown in Example 2, demonstrating the stability of such sensors after storage;
- FIG. 4 is a graph comparing the response of glucose sensors, made in accordance with an embodiment of the invention featuring a spacer layer as in Example 3. to blood doped with glucose to give levels near the same concentrations as the standard solutions;
- FIG. 5 is a graph illustrating the response of a lactate sensor made as in
- FIG. 6 is a graph illustrating the linearity of fluorescence signal response to various levels of lactate for the lactate sensor of Example 4.
- FIG. 7 is a graph illustrating the response of a cholesterol sensor made as shown in Example 5;
- FIG. 8 is a schematic representation of a test apparatus for measuring an output signal amplitude of a luminescent optical sensor as described herein;
- FIG. 9 is a graph illustrating the response of a creatinine sensor made as shown in Example 6; and FIG. 10 is a graph illustrating the proportional fluorescence signal response to various levels of creatinine for the creatinine sensors of Example 6.
- Polymeric sensing layer refers to articles such as membranes or thin detection layers made of a composition which exhibits the quenching of luminescent energy by a gas such as oxygen (O 2 ), and can be used for quantitative and qualitative determination of the gas concentration in the environment being measured.
- the sensing layer or membrane comprises a polymeric material containing at least one luminescent dye species preferably well-dispersed in the polymeric material.
- Luminescence means light emitted from a molecule by radiative dissipation of energy from an electronically excited state.
- Fluorescence means luminescence resulting from the transition between states of identical multiplicity, typically between the lowest excited singlet state and the singlet ground state of the molecule.
- Phosphorescence means luminescence resulting from the transition between states of differing multiplicity, typically between the lowest excited triplet state and the singlet ground state.
- Light-transmissive materials refers to materials preferably transmitting at least about 95% of electromagnetic radiation used to induce electronic excitations in luminescent material which result in emissions, more preferably at least about 99%o as measured by the transmission mode.
- FIG. 1 depicts an embodiment of an optical sensor 20 in accordance with the disclosure in simplified cross-sectional view.
- Sensor 20 comprises (from top to bottom) a rapidly hydrating gas-permeable cover layer 10; an enzymatic layer 11 containing an oxidative enzyme also in a water permeable and oxygen-permeable matrix; an oxygen sensing layer 12 containing luminescent dye in a light- transmissive. oxygen-permeable matrix: and a light-transmissive substrate 13. Further description of each layer is set forth below.
- the light transmissive substrate 13 is preferably supplied to provide a surface for deposition of the other layers of the oxidative enzyme sensor. It must be light transmissive to allow the excitation radiation from a source situated on the uncoated side of the substrate to pass to the oxygen sensing layer 12, and the luminescent energy emitted from the oxygen sensing layer 12 pass back to the detection optics also situated on the uncoated side of the substrate.
- the substrate should have a relatively low permeability to gases, especially oxygen, so as not to significantly influence the response of the oxygen sensing layer.
- An exemplary and nonlimiting list of suitable substrates includes MYLAR*; polyethyleneterephthalate (PET); SARAN ® : and glass.
- the substrate may be flexible or rigid, according to the particular demands of the desired end use.
- the light-transmissive substrate is preferably polymeric and has a permeability of at most about 0.05 Barrers. more preferably at most about 0.005 Barrers, and most preferably at most about 0.0005 Barrers, as measured by the methods disclosed inJ. Membrane Sci. 9. 53 (1981).
- Other suitable materials will be apparent to those of ordinary skill in the art and are intended to be within the scope of the present invention..
- the oxygen sensing layer 12 contains luminescent dye in a light-transmissive. oxygen-permeable matrix. Any luminescent dyes capable of excitation, oxygen- quenchable emission, and which may be readily dispersed within the chosen matrix material, may be used.
- Dyes which may be used in the present invention include, but are not limited to: metal complexes of ruthenium (II), osmium (II), iridium (III), rhodium (III) and chromium (III) ions complexed with 2,2 -bipyridine; 1.10- phenanthroline; 4,7-diphenyl-l,10-phenanthroline; 4,7-dimethyl-l,10- phenanthroline; 4,7-disulfonated-diphenyl- 1 , 10-phenanthroline: 5-bromo- 1.10- phenanthroline; 5-chloro-1.10-phenanthroline; 2-2' bi-2-thiazoline; 2.2'-bithiazole.
- metal complexes of ruthenium (II), osmium (II), iridium (III), rhodium (III) and chromium (III) ions complexed with 2,2 -bipyridine 1.10
- a-diimine ligands as disclosed in. e.g., U.S. Patent No. 4,752,115 and U.S. Patent No. 5,030,420; and porphyrin. chlorin or phthalocyanine complexes of VO 2 ⁇ . Cu 2 ⁇ Zn 2 ⁇ Pt 2* and Pd 2 such as is disclosed in U.S. Patent Nos. 4.810,655 and 5.043.286 and International application number PCT/EP97/03915.
- a particular fluorescent dye material may be synthesized for a particular use with a given polymeric material based on the desired K s , (i.e.. Stern-Volmer constant) of the polymeric sensing membrane.
- luminescent dye molecules which may be used include tris-(4,7-diphenyl-1.10-phenanthroline) Ru (II); octaethyl-Pt-porphyrin; octaethyl-Pt-porphyrin ketone; tetrabenzo-Pt-porphyrin; tetraphenyl-Pt-porphyrin: meso-tetraphenyl-tetrabenzo-Pt-poiphyrin; tetracyclohexenyl-Pt-porphyrin; octaethyl- Pt-chlorin; and tetraphenyl-Pt-chlorin.
- the light-transmissive. oxygen-permeable matrices may comprise a copolymer made by selecting a first homopolymer comprised of first monomeric units, the first homopolymer having a first oxygen permeability value; selecting a second homopolymer comprised of second monomeric units, the second homopolymer having a second oxygen permeability value that is higher than the first permeability value; and copolymerizing the first and second monomeric units to obtain a copolymer having an intermediate oxygen permeability value, i.e.. between the first and second permeabilites values, the intermediate permeability providing the desired permeability for the desired oxygen sensing formulation, such as described in copending and commonly assigned U.S.
- the oxygen sensing layer may further comprise a particulate filler material, in an amount effective to prevent the influence of changes in the sample absorbance and reflectance characteristics as disclosed in United States application number 09/009,914 and incorporated herein by reference.
- the filler material appears to effectively eliminate light transmission through the sensor. Inclusion of the scattering filler is particularly advantageous for measurements involving luminescence amplitude or amplitude ratios. Accordingly, particles of, e.g., TiO : , zinc oxide, antimony trioxide, barium sulfate, magnesium oxide, and mixtures thereof, and in particular.
- TiO 2 or BaSO 4 may be added in a range of 0 to about 95 wt% (based on the total weight of the oxygen sensing layer material), preferably 1 to 50wt%o. and more preferably 5 to 50wt%.
- the oxygen sensing layer 12 is deposited, preferably, as a continuous layer, e.g., as a membrane, on light-transmissive substrate 13. Standard coating techniques known in the art. such as described in the Examples herein, may be used.
- the enzymatic layer 11 includes an oxygen consuming or oxidase based enzyme in an oxygen-permeable matrix which is rapidly hydrated and, which is deposited on the oxygen-sensing layer 12.
- Rapidly hydrating is meant that water is absorbed rapidly, to enable ions and small charged or water soluble molecules to diffuse through the membrane at about the diffusion speed of the water.
- Rapidly hydrating materials which may be used to embed the enzyme in the enzyme layer include poly (vinyl alcohol) or (PVOH), crosslinked poly(vinyl alcohol) or (x-
- the matrix of the enzyme layer 11 should, after hydration. be freely permeable to water and to the substrates of the oxidase enxyme e.g. oxygen and glucose for example, but it is not necessary that the matrix be light-transmissive.
- the enzymatic layer need not also function as a "light shield", i.e., attenuate the effects of sample light scattering as described hereinabove.
- the enzymatic layer can be specifically optimized to pass substrates and products, e.g., glucose lactate creatinine and oxygen, to the immobilized enzymes in the enzymatic layer, and preserve the enzymes in an active state.
- the optical enzyme-based sensors of this disclosure are useful for measuring the concentration of analytes which are substrates of the immobilized oxidative enzymes.
- Such enzymes include, without limitation, glucose oxidase. cholesterol oxidase, lactate oxidase and sarcosine oxidase.
- the enzymatic layer may also comprise an enzyme mixture, such as an enzyme cascade, which allows for the detection of analytes which cannot directly, practically or possibly be the subject of enzymatic oxidation, such as creatinine.
- Creatinine is an end product of nitrogen metabolism. In healthy individuals, creatinine is transported from blood to urine by the kidney glomeruli and then excreted in the urine without reabsorption. As such, creatinine is an important diagnostic index of kidney function and muscle diseases.
- creatinine amidohydrase (“CA”)
- creatine amidinohydrolase (“CF “ )
- SO sarcosine oxidase
- the depletion of oxygen or (O 2 ) is measurable by the oxygen sensing layer.
- the amount of creatinine in the sample (being directly proportional to the amount of sarcosine oxidized) may be quantitatively determined.
- Another embodiment of the present invention includes a rapidly hydrating cover or spacer layer 10 over the enzymatic layer 11.
- Cover layer 10 ensures more accurate oxygen readings, i.e., those which are not skewed by oxygen concentration effects caused by red blood cell contact with the sensor.
- red blood cells RBCs
- the principal of operation of the present application is based on the oxidization, e.g., of available glucose in the blood sample by the immobilized glucose oxidase (i.e., the detection of oxygen is directly correlated to the glucose concentration), the depletion of oxygen proximate to the membrane will be high.
- red blood cells in contact with the sensor will respond to the low oxygen level at the enzyme layer surface and release their bound oxygen, thus skewing the results obtained.
- provision of a spacer layer 10 over the enzymatic layer 11 ensures that any oxygen released from the RBCs that are proximate to the spacer layer 10 is forced to follow a longer diffusion path than the dissolved oxygen from the blood plasma brought into the membrane sensor under short term “wet up” and normal measurement conditions.
- the RBCs are therefore, through equilibrium concentration effects, effectively delayed or prevented from "dumping" their payload of oxygen into the membrane to counter the loss of oxygen immediately adjacent to the oxygen sensor layer.
- Suitable material for the spacer layer includes poly(vinyl alcohol), which may be preferably crosslinked for chemical and physical durability.
- Other suitable materials include any of the rapidly hydrating materials which may be used in used in the enzyme layer 11 itself.
- FIG. 8 describes a suitable device for measuring the luminescent amplitude response of optical sensors 20 in the present invention.
- the measurement apparatus 140 is comprised of a flow cell assembly 60 and a source and detector sub-system 100.
- LED source 152 and lens 154 direct excitation light through filter 162 into one leg 182 of fiber optic splitter 180 (e.g., from American Laubscher Corp., Farmingdale. NY).
- the luminescent light signal returning from the sensor 20 through fiber cable 80 and leg 184 is passed through filter 168 and aperture 158 before detection by photodiode 172 (e.g., from Hamamatsu Corporation. Bridgewater, NJ).
- the output current of emission detector 172 is amplified with a preamplifier 174, such as a Stanford Research SR570 current preamplifier (Stanford Research Systems, Inc., Sunnyvale, CA), and converted to a voltage and recorded for use in analysis.
- a preamplifier 174 such as a Stanford Research SR570 current preamplifier (Stanford Research Systems, Inc., Sunnyvale, CA)
- the luminescent material 2 employing a different dye, such as octaethyl-Pt-porphyrin (OEP) as the luminescent material 2.
- OEP octaethyl-Pt-porphyrin
- the sensor detection layer 14 of optical sensor 20 is brought in contact with the sample by means of flow cell assembly 60, the optical emission signal that is generated and subsequently conveyed by fiber optic 80 to the source and detector subsystem 100 will be representative of the luminescent amplitude response.
- the apparatus described in U.S. Patent Application No. 08/617.714. The following illustrative and nonlimiting examples are intended to demonstrate certain aspects of the present invention.
- EXA M PLE 1 Glucose sensors were made in several steps.
- THF tetrahydrofuran
- a form was made by separating the faces of two glass plates about 2mm apart and providing a rubber sealing gasket therebetween, providing a space in the gasket to allow material to be added to the form.
- the form was filled with about 32g of the above solution and heated to 60° C for 42 hours in a dry box flushed with nitrogen. The mixture was polymerized to form a solid, then the material was removed and dissolved in about 150ml of chloroform, glass filtered, and precipitated by adding the chloroform solution to 4 /of methanol. The precipitate was dried in a vacuum at 40°C for three days.
- an enzymatic layer comprising glucose oxidase was made and deposited onto the oxygen sensing layer as follows. 2mg of glucose oxidase was dissolved in 200mg of deionized water. 1.8g of a methanol solution of a random copolymer made from starting monomers N,N-dimethylacrylamide (15%>) and N-tert- butylacrylamide monomers was added to the glucose oxidase solution, to provide a homogenous, pale yellow solution upon vortexing. The enzyme layer was formed by spin casting the pale yellow solution on the oxygen sensing layer for 20 seconds at 2000 RPM. The finished sensors were dried at room temperature under vacuum for three hours before testing. FIG.
- FIG. 2 is a graph illustrating the linearity of fluorescence signal response to various levels of glucose in standard buffer solution for the sensor. The response stabilized after about 20 minutes of testing, and no enzyme loss corresponding to signal loss was observed after about two hours of testing after wet up had occurred.
- EXAM PL E 2 Another embodiment of a glucose sensor was made in much the same manner as in Example 1 except that the enzyme layer was prepared by combining 2g of an aqueous solution of 13%) "crosslinker PVOH” (poly(vinyl alcohol), including N- methyl-4(-formalstyryl)pyridinium crosslinking agent) (Polysciences Inc.), 2mg of glucose oxidase, and 1 g deionized water to form the solution from which the enzyme layer was spin cast onto the oxygen sensing layer-coated substrate as above.
- the glucose sensors were placed in a UV box for 10 minutes to crosslink the PVOH, removed, and stored under vacuum overnight at room temperature. The sensors were stored in uncovered, Petri dishes in a drawer for three and one half months, whereupon sensor response, wet-up, and stability were tested as above.
- FIG. 3 illustrates the test results for example 2. Testing was performed with the optical instrument described in FIG. 8. The glucose sensors, despite the storage conditions, showed excellent activity when exposed to varying levels of glucose. The response was found to be comparable to the sensors made in Example 1 and actually a more rapid rate of oxygen uptake per amount of enzyme used was found in comparison to the sensors made with the acrylamide matrix.. Also the wet up period was found to be nearly instantaneous as dry sensors gave similarly fast kinetics on the first aqueous sample addition.
- EXAM PLE 3 To demonstrate the benefits provided by the spacer layer disclosed herein, the glucose sensors made as in Example 1 were provided with spacer layers as follows. A layer of crosslinked PVOH was laid down in stripes from a solution prepared by mixing 250mg of the crosslinker PVOH solution with 750mg of a 5% aqueous solution of PVOH (average molecular weight of the polymer chains 124,000 to 186,000). The stripes were allowed to dry on the benchtop for a few hours before UV curing and vacuum storage. Testing was performed with the optical instrument described in FIG. 8. with a preamplifier 174 sensitivity of lOOpA/V. In this case a single shot protocol was used where a glucose containing blood sample was passed over a hydrated sensor. As illustrated in FIG. 4, blood has very little effect on suppressing the initial response of the glucose sensors when measured within the first half minute. Rather, the increasing glucose level gives rise to an increased rate of oxygen consumption evidenced by the rapidly rising luminescence signal level. EXA MPLE 4
- a lactate sensor was made in much the same manner as example 2 above.
- the enzyme layer solution was prepared by combining 2g of lactate oxidase, lg of crosslinker PVOH solution, lg of a 7% aqueous solution of PVOH, and lg of deionized water.
- the sensors were tested as above and the data are presented in FIGs. 5 and 6.
- FIGs. 5 and 6 demonstrate the good response and linearity of these sensors.
- EXA MPLE 5 Sensors comprising cholesterol oxidase in the enzyme layer were made generally as above to produce a cholesterol sensor. The response curve was measured as above and the data are shown in the graph of FIG. 7. EXAMPLE 6
- An optical sensor for measuring creatinine was prepared using the same basic procedures outlined in Examples 1 and 2 for making enzyme sensors except that 2 mg of the dye /wes ⁇ -tetraphenyl-tetrabenzo-Pt-porphyrin (mTPTBP) was substituted in place of octaethyl-Pt-porphyrin (OEP) in making the oxygen sensing layer.
- mTPTBP dye /wes ⁇ -tetraphenyl-tetrabenzo-Pt-porphyrin
- OEP octaethyl-Pt-porphyrin
- An enzymatic layer was prepared by adding 13mg creatinine amidohydrase ("CA”), 20mg creatine amidinohydrolase (“CI”), and 23mg sarcosine oxidase ("SO”), to lmg of 7% aqueous solution of PVOH. This solution was spin coated onto the oxygen-sensing layer residing on a transparent substrate, and which had been previously prepared. A third spacer or cover layer was spin coated onto the enzymatic layer from a 10%> methanol solution of polyhydroxyethylmethacrylate, whereupon the sensor was cured by drying in a fume hood under ambient conditions.
- CA creatinine amidohydrase
- CI creatine amidinohydrolase
- SO sarcosine oxidase
- the sensors were tested by exposing the sensor to increasing levels of creatinine ranging from 2.5 mg/dl, 5.0 mg/dl. 12.5 mg/dl. 25 mg/dl and finally 50 mg/dl and interspersed with 0.05 M phosphate buffer samples containing no creatinine..
- the excitation wavelength used for the sensors was 612 nm while the luminous intensity at 775 nm was measured on a model LS50-b Spectrofluorimeter (available from Perkin Elmer. Norwlk CT) and equipped with a flow cell to hold the sensors and samples
- the actual luminescence response for such a sensor is presented in FIG. 9 and shows that the response is rapid and proportional to increasing levels of creatinine.
- the plot in FIG. 10 shows the response of several such creatinine sensors.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU51883/99A AU5188399A (en) | 1998-08-21 | 1999-08-19 | Optical oxidative enzyme-based sensors |
JP2000566457A JP2002523733A (en) | 1998-08-21 | 1999-08-19 | Optical sensor based on oxidase |
CA002340983A CA2340983A1 (en) | 1998-08-21 | 1999-08-19 | Optical oxidative enzyme-based sensors |
EP99936915A EP1112374A1 (en) | 1998-08-21 | 1999-08-19 | Optical oxidative enzyme-based sensors |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/137,616 US6107083A (en) | 1998-08-21 | 1998-08-21 | Optical oxidative enzyme-based sensors |
US09/137,616 | 1998-08-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000011205A1 true WO2000011205A1 (en) | 2000-03-02 |
Family
ID=22478266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB1999/001451 WO2000011205A1 (en) | 1998-08-21 | 1999-08-19 | Optical oxidative enzyme-based sensors |
Country Status (6)
Country | Link |
---|---|
US (1) | US6107083A (en) |
EP (1) | EP1112374A1 (en) |
JP (1) | JP2002523733A (en) |
AU (1) | AU5188399A (en) |
CA (1) | CA2340983A1 (en) |
WO (1) | WO2000011205A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6872573B2 (en) | 2003-01-02 | 2005-03-29 | Bayer Corporation | Fluorescent creatinine assay |
US7222024B2 (en) | 2002-12-31 | 2007-05-22 | Kuo-Jeng Wang | Method for determining the concentration of blood glucose |
US8320986B2 (en) | 2003-04-04 | 2012-11-27 | Transpacific Systems, Llc | Method for determining the resolution of blood glucose |
CN103091264A (en) * | 2011-10-31 | 2013-05-08 | 爱科来株式会社 | Analytical instrument and analytical method |
US10947577B2 (en) | 2012-02-16 | 2021-03-16 | 3M Innovative Properties Company | Biological sterilization indicator devices and methods of use |
Families Citing this family (155)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6395506B1 (en) * | 1991-04-18 | 2002-05-28 | Becton, Dickinson And Company | Device for monitoring cells |
US7657297B2 (en) * | 2004-05-03 | 2010-02-02 | Dexcom, Inc. | Implantable analyte sensor |
US6036924A (en) | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6949816B2 (en) | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
US6331438B1 (en) | 1999-11-24 | 2001-12-18 | Iowa State University Research Foundation, Inc. | Optical sensors and multisensor arrays containing thin film electroluminescent devices |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
US7041468B2 (en) | 2001-04-02 | 2006-05-09 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
US6960466B2 (en) | 2001-05-31 | 2005-11-01 | Instrumentation Laboratory Company | Composite membrane containing a cross-linked enzyme matrix for a biosensor |
EP1404233B1 (en) | 2001-06-12 | 2009-12-02 | Pelikan Technologies Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
AU2002312521A1 (en) | 2001-06-12 | 2002-12-23 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
US7033371B2 (en) | 2001-06-12 | 2006-04-25 | Pelikan Technologies, Inc. | Electric lancet actuator |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US7344507B2 (en) | 2002-04-19 | 2008-03-18 | Pelikan Technologies, Inc. | Method and apparatus for lancet actuation |
WO2002100254A2 (en) | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
WO2002100461A2 (en) | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Method and apparatus for improving success rate of blood yield from a fingerstick |
US8260393B2 (en) | 2003-07-25 | 2012-09-04 | Dexcom, Inc. | Systems and methods for replacing signal data artifacts in a glucose sensor data stream |
US9282925B2 (en) | 2002-02-12 | 2016-03-15 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US8010174B2 (en) | 2003-08-22 | 2011-08-30 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US8858434B2 (en) | 2004-07-13 | 2014-10-14 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7828728B2 (en) | 2003-07-25 | 2010-11-09 | Dexcom, Inc. | Analyte sensor |
US9247901B2 (en) | 2003-08-22 | 2016-02-02 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7713214B2 (en) | 2002-04-19 | 2010-05-11 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US7892185B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7371247B2 (en) | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7002670B2 (en) * | 2002-06-12 | 2006-02-21 | Baxter International Inc. | Optical sensor and method for measuring concentration of a chemical constituent using its intrinsic optical absorbance |
US7248912B2 (en) * | 2002-10-31 | 2007-07-24 | The Regents Of The University Of California | Tissue implantable sensors for measurement of blood solutes |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US6999807B2 (en) * | 2003-01-23 | 2006-02-14 | Scimed Life Systems, Inc. | pH measuring balloon |
DE602004028463D1 (en) | 2003-05-30 | 2010-09-16 | Pelikan Technologies Inc | METHOD AND DEVICE FOR INJECTING LIQUID |
US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
JP2005151972A (en) * | 2003-07-10 | 2005-06-16 | F Hoffmann La Roche Ag | Nanoparticle for optical sensor |
CA2473069C (en) * | 2003-07-11 | 2014-03-18 | F. Hoffmann-La Roche Ag | Castable diffusion membrane for enzyme-based sensor application |
EP1502957B1 (en) * | 2003-07-11 | 2008-08-27 | F. Hoffmann-La Roche Ag | Castable diffusion membrane for enzyme-based sensor application |
US8423113B2 (en) | 2003-07-25 | 2013-04-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
US7651596B2 (en) | 2005-04-08 | 2010-01-26 | Dexcom, Inc. | Cellulosic-based interference domain for an analyte sensor |
EP1648298A4 (en) | 2003-07-25 | 2010-01-13 | Dexcom Inc | Oxygen enhancing membrane systems for implantable devices |
US20050176136A1 (en) * | 2003-11-19 | 2005-08-11 | Dexcom, Inc. | Afinity domain for analyte sensor |
US8060173B2 (en) | 2003-08-01 | 2011-11-15 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8160669B2 (en) | 2003-08-01 | 2012-04-17 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8275437B2 (en) | 2003-08-01 | 2012-09-25 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8886273B2 (en) | 2003-08-01 | 2014-11-11 | Dexcom, Inc. | Analyte sensor |
US7986986B2 (en) | 2003-08-01 | 2011-07-26 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8369919B2 (en) | 2003-08-01 | 2013-02-05 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9135402B2 (en) | 2007-12-17 | 2015-09-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
US7494465B2 (en) | 2004-07-13 | 2009-02-24 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US8761856B2 (en) | 2003-08-01 | 2014-06-24 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US20190357827A1 (en) | 2003-08-01 | 2019-11-28 | Dexcom, Inc. | Analyte sensor |
US7774145B2 (en) | 2003-08-01 | 2010-08-10 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8788006B2 (en) | 2003-08-01 | 2014-07-22 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US20140121989A1 (en) | 2003-08-22 | 2014-05-01 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
US8233959B2 (en) | 2003-08-22 | 2012-07-31 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
US20050059140A1 (en) * | 2003-09-12 | 2005-03-17 | Andrea Liebmann-Vinson | Methods of surface modification to enhance cell adhesion |
US7198855B2 (en) * | 2003-09-12 | 2007-04-03 | Becton, Dickinson And Company | Methods of surface modification of a flexible substrate to enhance cell adhesion |
US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
EP1680014A4 (en) | 2003-10-14 | 2009-01-21 | Pelikan Technologies Inc | Method and apparatus for a variable user interface |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
US8615282B2 (en) | 2004-07-13 | 2013-12-24 | Dexcom, Inc. | Analyte sensor |
WO2005051170A2 (en) | 2003-11-19 | 2005-06-09 | Dexcom, Inc. | Integrated receiver for continuous analyte sensor |
US8287453B2 (en) | 2003-12-05 | 2012-10-16 | Dexcom, Inc. | Analyte sensor |
US8423114B2 (en) | 2006-10-04 | 2013-04-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8532730B2 (en) | 2006-10-04 | 2013-09-10 | Dexcom, Inc. | Analyte sensor |
DE602004029092D1 (en) | 2003-12-05 | 2010-10-21 | Dexcom Inc | CALIBRATION METHODS FOR A CONTINUOUSLY WORKING ANALYTIC SENSOR |
US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8364231B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
EP3241490A1 (en) * | 2003-12-08 | 2017-11-08 | DexCom, Inc. | Systems and methods for improving electrochemical analyte sensors |
EP2329763B1 (en) | 2003-12-09 | 2017-06-21 | DexCom, Inc. | Signal processing for continuous analyte sensor |
EP1706026B1 (en) | 2003-12-31 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US8808228B2 (en) | 2004-02-26 | 2014-08-19 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US8792955B2 (en) | 2004-05-03 | 2014-07-29 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8277713B2 (en) | 2004-05-03 | 2012-10-02 | Dexcom, Inc. | Implantable analyte sensor |
EP1751546A2 (en) | 2004-05-20 | 2007-02-14 | Albatros Technologies GmbH & Co. KG | Printable hydrogel for biosensors |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
EP1765194A4 (en) | 2004-06-03 | 2010-09-29 | Pelikan Technologies Inc | Method and apparatus for a fluid sampling device |
US7783333B2 (en) | 2004-07-13 | 2010-08-24 | Dexcom, Inc. | Transcutaneous medical device with variable stiffness |
US20060270922A1 (en) | 2004-07-13 | 2006-11-30 | Brauker James H | Analyte sensor |
US8097725B2 (en) * | 2004-12-03 | 2012-01-17 | Roche Diagnostics Operations, Inc. | Luminescent indicator dye and optical sensor |
US20060121547A1 (en) * | 2004-12-03 | 2006-06-08 | Mcintire Mark | Diffusion layer for an enzyme-based sensor application |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US20060216209A1 (en) * | 2005-02-14 | 2006-09-28 | Braig James R | Analyte detection system with distributed sensing |
US8744546B2 (en) | 2005-05-05 | 2014-06-03 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
WO2007143225A2 (en) | 2006-06-07 | 2007-12-13 | Abbott Diabetes Care, Inc. | Analyte monitoring system and method |
US20080306444A1 (en) | 2007-06-08 | 2008-12-11 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
AT505337B1 (en) * | 2007-06-14 | 2009-08-15 | Joanneum Res Forschungsgesells | SENSOR FOR THE DETECTION OF GASES |
WO2009051901A2 (en) | 2007-08-30 | 2009-04-23 | Pepex Biomedical, Llc | Electrochemical sensor and method for manufacturing |
WO2009032760A2 (en) | 2007-08-30 | 2009-03-12 | Pepex Biomedical Llc | Electrochmical sensor and method for manufacturing |
EP4159114B1 (en) | 2007-10-09 | 2024-04-10 | DexCom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
US8417312B2 (en) | 2007-10-25 | 2013-04-09 | Dexcom, Inc. | Systems and methods for processing sensor data |
US8290559B2 (en) | 2007-12-17 | 2012-10-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
WO2009126900A1 (en) | 2008-04-11 | 2009-10-15 | Pelikan Technologies, Inc. | Method and apparatus for analyte detecting device |
WO2010056878A2 (en) | 2008-11-14 | 2010-05-20 | Pepex Biomedical, Llc | Electrochemical sensor module |
WO2010056876A2 (en) | 2008-11-14 | 2010-05-20 | Pepex Biomedical, Llc | Manufacturing electrochemical sensor module |
US8951377B2 (en) | 2008-11-14 | 2015-02-10 | Pepex Biomedical, Inc. | Manufacturing electrochemical sensor module |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US9446194B2 (en) | 2009-03-27 | 2016-09-20 | Dexcom, Inc. | Methods and systems for promoting glucose management |
US9378443B2 (en) | 2009-05-14 | 2016-06-28 | Ascensia Diabetes Care Holding Ag | Calibration coded sensors and apparatus, systems and methods for reading same |
GB2470757B (en) * | 2009-06-04 | 2013-11-06 | Haemaflow Ltd | Non invasive gas analysis |
US9949672B2 (en) | 2009-12-17 | 2018-04-24 | Ascensia Diabetes Care Holdings Ag | Apparatus, systems and methods for determining and displaying pre-event and post-event analyte concentration levels |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
WO2012064648A1 (en) | 2010-11-12 | 2012-05-18 | Bayer Healthcare Llc | Auto-coded analyte sensors and apparatus, systems, and methods for detecting same |
JP6141827B2 (en) | 2011-04-15 | 2017-06-07 | デックスコム・インコーポレーテッド | Method of operating a system for measuring an analyte and sensor system configured to implement the method |
US9504162B2 (en) | 2011-05-20 | 2016-11-22 | Pepex Biomedical, Inc. | Manufacturing electrochemical sensor modules |
KR20140082642A (en) | 2011-07-26 | 2014-07-02 | 글리젠스 인코포레이티드 | Tissue implantable sensor with hermetically sealed housing |
US10561353B2 (en) | 2016-06-01 | 2020-02-18 | Glysens Incorporated | Biocompatible implantable sensor apparatus and methods |
US10660550B2 (en) | 2015-12-29 | 2020-05-26 | Glysens Incorporated | Implantable sensor apparatus and methods |
US11224367B2 (en) | 2012-12-03 | 2022-01-18 | Pepex Biomedical, Inc. | Sensor module and method of using a sensor module |
US11045124B2 (en) | 2014-06-04 | 2021-06-29 | Pepex Biomedical, Inc. | Electrochemical sensors and methods for making electrochemical sensors using advanced printing technology |
US20190000361A1 (en) * | 2015-12-09 | 2019-01-03 | The Texas A&M University System | Implantable biosensors |
US10638962B2 (en) | 2016-06-29 | 2020-05-05 | Glysens Incorporated | Bio-adaptable implantable sensor apparatus and methods |
US10638979B2 (en) | 2017-07-10 | 2020-05-05 | Glysens Incorporated | Analyte sensor data evaluation and error reduction apparatus and methods |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
AU2018354120A1 (en) | 2017-10-24 | 2020-04-23 | Dexcom, Inc. | Pre-connected analyte sensors |
US11278668B2 (en) | 2017-12-22 | 2022-03-22 | Glysens Incorporated | Analyte sensor and medicant delivery data evaluation and error reduction apparatus and methods |
US11255839B2 (en) | 2018-01-04 | 2022-02-22 | Glysens Incorporated | Apparatus and methods for analyte sensor mismatch correction |
CN111707780A (en) * | 2020-07-03 | 2020-09-25 | 安徽盛世新能源材料科技有限公司 | Chemical detection method for content of antimony trioxide |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4680268A (en) * | 1985-09-18 | 1987-07-14 | Children's Hospital Medical Center | Implantable gas-containing biosensor and method for measuring an analyte such as glucose |
US4689309A (en) * | 1985-09-30 | 1987-08-25 | Miles Laboratories, Inc. | Test device, method of manufacturing same and method of determining a component in a sample |
US4752115A (en) * | 1985-02-07 | 1988-06-21 | Spectramed, Inc. | Optical sensor for monitoring the partial pressure of oxygen |
US4810655A (en) * | 1985-07-03 | 1989-03-07 | Abbott Laboratories | Method for measuring oxygen concentration |
EP0409032A2 (en) * | 1989-07-19 | 1991-01-23 | Gesellschaft für Biotechnologische Forschung mbH (GBF) | Optical biosensor |
US5030420A (en) * | 1982-12-23 | 1991-07-09 | University Of Virginia Alumni Patents Foundation | Apparatus for oxygen determination |
US5208147A (en) * | 1988-07-21 | 1993-05-04 | Radiometer A/S | Means for measuring a characteristic in a sample fluid |
DE4323277A1 (en) * | 1992-07-15 | 1994-01-20 | Seiko Instr Inc | Appts. for quantitative analysis of dissolved substances - is by chemical developed luminescence of immobilised enzyme treated body fluid, used e.g. for determn. of glucose or lactic acid levels in blood serum samples |
US5352348A (en) * | 1987-04-09 | 1994-10-04 | Nova Biomedical Corporation | Method of using enzyme electrode |
WO1995008107A1 (en) * | 1993-09-13 | 1995-03-23 | Optical Sensors Incorporated | A ratiometric fluorescence method to measure oxygen |
EP0693271A1 (en) * | 1994-07-18 | 1996-01-24 | Minimed Inc. | Optical glucose sensor |
US5520883A (en) * | 1987-11-13 | 1996-05-28 | Miles Inc. | Test devices for determination of glucose |
WO1998015645A1 (en) * | 1996-10-08 | 1998-04-16 | Photonics Biosystems | Microbiological assessment method and device utilizing oxygen gradient sensing |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE545464A (en) * | 1955-02-23 | 1900-01-01 | ||
US3992158A (en) * | 1973-08-16 | 1976-11-16 | Eastman Kodak Company | Integral analytical element |
DE2508637C3 (en) * | 1975-02-28 | 1979-11-22 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen | Arrangement for the optical measurement of blood gases |
US4042335A (en) * | 1975-07-23 | 1977-08-16 | Eastman Kodak Company | Integral element for analysis of liquids |
JPS568549A (en) * | 1979-07-02 | 1981-01-28 | Fuji Photo Film Co Ltd | Multilayer chemical analyzing material |
US4734375A (en) * | 1980-05-27 | 1988-03-29 | Miles Laboratories, Inc. | Ion specific test method |
US4476870A (en) * | 1982-03-30 | 1984-10-16 | The United States Of America As Represented By The Department Of Health And Human Services | Fiber optic PO.sbsb.2 probe |
DE3369801D1 (en) * | 1982-10-06 | 1987-03-19 | Avl Ag | Measurement device for determining the carbon dioxide content of a sample |
AT379688B (en) * | 1982-11-22 | 1986-02-10 | List Hans | SENSOR ELEMENT FOR DETERMINING THE O2 CONTENT OF A SAMPLE |
JPS59171864A (en) * | 1983-03-18 | 1984-09-28 | Fuji Photo Film Co Ltd | Multi-layered analytical element for quantitative analysis of bilirubin |
CA1222438A (en) * | 1983-05-12 | 1987-06-02 | Steven C. Charlton | Unified test means for ion determination |
US4649123A (en) * | 1983-05-12 | 1987-03-10 | Miles Laboratories, Inc. | Ion test means having a hydrophilic carrier matrix |
JPS60108753A (en) * | 1983-11-18 | 1985-06-14 | Fuji Photo Film Co Ltd | Multilayer chemical analysis element |
US4670218A (en) * | 1984-02-24 | 1987-06-02 | Miles Laboratories, Inc. | Ion test means having a porous carrier matrix |
JPS61245057A (en) * | 1985-04-23 | 1986-10-31 | Fuji Photo Film Co Ltd | Integral type multi-layered analyzing element |
EP0227815A4 (en) * | 1985-07-03 | 1988-06-23 | Internat Biomedics Inc | Methods of measuring oxygen concentration. |
US5043286A (en) * | 1985-07-03 | 1991-08-27 | Abbott Laboratories | Method and sensor for measuring oxygen concentration |
US4824789B1 (en) * | 1986-10-10 | 1996-08-13 | Minnesota Mining & Mfg | Gas sensor |
US4919891A (en) * | 1986-04-18 | 1990-04-24 | Minnesota Mining And Manufacturing Company | Sensor with overcoating and process for making same |
US4895156A (en) * | 1986-07-02 | 1990-01-23 | Schulze John E | Sensor system using fluorometric decay measurements |
US4861727A (en) * | 1986-09-08 | 1989-08-29 | C. R. Bard, Inc. | Luminescent oxygen sensor based on a lanthanide complex |
US5190729A (en) * | 1986-09-08 | 1993-03-02 | C. R. Bard, Inc. | Luminescent oxygen sensor based on a lanthanide complex |
US5075127A (en) * | 1986-10-10 | 1991-12-24 | Minnesota Mining And Manufacturing Company | Sensor with overcoating and process for making same |
US4808539A (en) * | 1987-04-15 | 1989-02-28 | Technicon Instruments Corporation | Compounds, reagents and procedures for determining cations |
IL84422A (en) * | 1987-04-15 | 1993-03-15 | Technicon Instr | Process for the preparation of chromogenic cryptahemispherands |
US4716363A (en) * | 1987-05-08 | 1987-12-29 | Hewlett-Packard Company | Exponential decay time constant measurement using frequency of offset phase-locked loop: system and method |
AT389590B (en) * | 1987-05-27 | 1989-12-27 | Avl Verbrennungskraft Messtech | METHOD FOR THE CONTINUOUS, QUANTITATIVE DETERMINATION OF SULFUR DIOXIDE AND ARRANGEMENT FOR IMPLEMENTING THE METHOD |
AT388248B (en) * | 1987-07-20 | 1989-05-26 | Avl Verbrennungskraft Messtech | COVER LAYER, PREFERABLY FOR SAMPLE-SIDE ATTACHMENT TO OPTICAL ION SENSORS |
US4974929A (en) * | 1987-09-22 | 1990-12-04 | Baxter International, Inc. | Fiber optical probe connector for physiologic measurement devices |
DK163194C (en) * | 1988-12-22 | 1992-06-22 | Radiometer As | METHOD OF PHOTOMETRIC IN VITRO DETERMINING A BLOOD GAS PARAMETER IN A BLOOD TEST |
US5173432A (en) * | 1987-12-14 | 1992-12-22 | The Dow Chemical Company | Apparatus and method for measuring the concentration or partial pressure of oxygen |
US5047350A (en) * | 1989-01-19 | 1991-09-10 | Eastman Kodak Company | Material and method for oxygen sensing |
DE3923950A1 (en) * | 1989-07-19 | 1991-01-31 | Biotechnolog Forschung Gmbh | FIBER OPTICAL SENSOR ARRANGEMENT FOR DETERMINING AN ANALYTIC, IN PARTICULAR OF GLUCOSE |
US5127405A (en) * | 1990-02-16 | 1992-07-07 | The Boc Group, Inc. | Biomedical fiber optic probe with frequency domain signal processing |
US5081042A (en) * | 1990-03-20 | 1992-01-14 | Minnesota Mining And Manufacturing Company | Ionic component sensor and method for making and using same |
US5081041A (en) * | 1990-04-03 | 1992-01-14 | Minnesota Mining And Manufacturing Company | Ionic component sensor and method for making and using same |
WO1992019957A2 (en) * | 1991-05-03 | 1992-11-12 | University Of Maryland At Baltimore | Method for optically measuring chemical analytes |
US5281825A (en) * | 1991-09-05 | 1994-01-25 | The University Of Maryland School Of Medicine | Phase fluorometry using a modulated electroluminescent lamp as a light source |
US6362175B1 (en) * | 1991-09-20 | 2002-03-26 | The Trustees Of The University Of Pennsylvania | Porphyrin compounds for imaging tissue oxygen |
US5453248A (en) * | 1992-03-09 | 1995-09-26 | Optical Sensors Incorporated | Cross-linked gas permeable membrane of a cured perfluorinated urethane polymer, and optical gas sensors fabricated therewith |
US5298144A (en) * | 1992-09-15 | 1994-03-29 | The Yellow Springs Instrument Company, Inc. | Chemically wired fructose dehydrogenase electrodes |
US5326531A (en) * | 1992-12-11 | 1994-07-05 | Puritan-Bennett Corporation | CO2 sensor using a hydrophilic polyurethane matrix and process for manufacturing |
US5341805A (en) * | 1993-04-06 | 1994-08-30 | Cedars-Sinai Medical Center | Glucose fluorescence monitor and method |
US5387329A (en) * | 1993-04-09 | 1995-02-07 | Ciba Corning Diagnostics Corp. | Extended use planar sensors |
US5387525A (en) * | 1993-09-03 | 1995-02-07 | Ciba Corning Diagnostics Corp. | Method for activation of polyanionic fluorescent dyes in low dielectric media with quaternary onium compounds |
US5462879A (en) * | 1993-10-14 | 1995-10-31 | Minnesota Mining And Manufacturing Company | Method of sensing with emission quenching sensors |
US5462858A (en) * | 1993-12-29 | 1995-10-31 | Eastman Kodak Company | Dry multilayer analytical elements for assaying transaminases |
DE69503897T2 (en) * | 1994-03-25 | 1999-01-14 | Novartis Ag | OPTICAL SENSOR FOR DETERMINING IONS |
DE69507465T2 (en) * | 1994-05-02 | 1999-06-24 | Novartis Ag | OPTICAL SENSOR SYSTEM FOR DETERMINING pH AND ION STRENGTH |
US5494562A (en) * | 1994-06-27 | 1996-02-27 | Ciba Corning Diagnostics Corp. | Electrochemical sensors |
US5464777A (en) * | 1994-09-26 | 1995-11-07 | Miles Inc. | Dry reagent for creatinine assay |
US5863460A (en) * | 1996-04-01 | 1999-01-26 | Chiron Diagnostics Corporation | Oxygen sensing membranes and methods of making same |
-
1998
- 1998-08-21 US US09/137,616 patent/US6107083A/en not_active Expired - Lifetime
-
1999
- 1999-08-19 CA CA002340983A patent/CA2340983A1/en not_active Abandoned
- 1999-08-19 JP JP2000566457A patent/JP2002523733A/en not_active Withdrawn
- 1999-08-19 AU AU51883/99A patent/AU5188399A/en not_active Abandoned
- 1999-08-19 EP EP99936915A patent/EP1112374A1/en not_active Withdrawn
- 1999-08-19 WO PCT/IB1999/001451 patent/WO2000011205A1/en not_active Application Discontinuation
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5030420A (en) * | 1982-12-23 | 1991-07-09 | University Of Virginia Alumni Patents Foundation | Apparatus for oxygen determination |
US4752115A (en) * | 1985-02-07 | 1988-06-21 | Spectramed, Inc. | Optical sensor for monitoring the partial pressure of oxygen |
US4810655A (en) * | 1985-07-03 | 1989-03-07 | Abbott Laboratories | Method for measuring oxygen concentration |
US4680268A (en) * | 1985-09-18 | 1987-07-14 | Children's Hospital Medical Center | Implantable gas-containing biosensor and method for measuring an analyte such as glucose |
US4689309A (en) * | 1985-09-30 | 1987-08-25 | Miles Laboratories, Inc. | Test device, method of manufacturing same and method of determining a component in a sample |
US5352348A (en) * | 1987-04-09 | 1994-10-04 | Nova Biomedical Corporation | Method of using enzyme electrode |
US5520883A (en) * | 1987-11-13 | 1996-05-28 | Miles Inc. | Test devices for determination of glucose |
US5208147A (en) * | 1988-07-21 | 1993-05-04 | Radiometer A/S | Means for measuring a characteristic in a sample fluid |
EP0409032A2 (en) * | 1989-07-19 | 1991-01-23 | Gesellschaft für Biotechnologische Forschung mbH (GBF) | Optical biosensor |
DE4323277A1 (en) * | 1992-07-15 | 1994-01-20 | Seiko Instr Inc | Appts. for quantitative analysis of dissolved substances - is by chemical developed luminescence of immobilised enzyme treated body fluid, used e.g. for determn. of glucose or lactic acid levels in blood serum samples |
WO1995008107A1 (en) * | 1993-09-13 | 1995-03-23 | Optical Sensors Incorporated | A ratiometric fluorescence method to measure oxygen |
EP0693271A1 (en) * | 1994-07-18 | 1996-01-24 | Minimed Inc. | Optical glucose sensor |
WO1998015645A1 (en) * | 1996-10-08 | 1998-04-16 | Photonics Biosystems | Microbiological assessment method and device utilizing oxygen gradient sensing |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7222024B2 (en) | 2002-12-31 | 2007-05-22 | Kuo-Jeng Wang | Method for determining the concentration of blood glucose |
DE10319295B4 (en) * | 2002-12-31 | 2008-04-03 | Transpacific Ip, Ltd. | Method for determining the concentration of glucose in the blood |
US8478536B2 (en) | 2002-12-31 | 2013-07-02 | Transpacific Systems, Llc | Method for determining the concentration of blood glucose |
US6872573B2 (en) | 2003-01-02 | 2005-03-29 | Bayer Corporation | Fluorescent creatinine assay |
US8320986B2 (en) | 2003-04-04 | 2012-11-27 | Transpacific Systems, Llc | Method for determining the resolution of blood glucose |
CN103091264A (en) * | 2011-10-31 | 2013-05-08 | 爱科来株式会社 | Analytical instrument and analytical method |
EP2592153A3 (en) * | 2011-10-31 | 2013-06-12 | ARKRAY, Inc. | Analytical instrument and analytical method |
US8993313B2 (en) | 2011-10-31 | 2015-03-31 | Arkray, Inc. | Analytical instrument and analytical method |
US10947577B2 (en) | 2012-02-16 | 2021-03-16 | 3M Innovative Properties Company | Biological sterilization indicator devices and methods of use |
Also Published As
Publication number | Publication date |
---|---|
AU5188399A (en) | 2000-03-14 |
CA2340983A1 (en) | 2000-03-02 |
JP2002523733A (en) | 2002-07-30 |
US6107083A (en) | 2000-08-22 |
EP1112374A1 (en) | 2001-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6107083A (en) | Optical oxidative enzyme-based sensors | |
Moreno-Bondi et al. | Oxygen optrode for use in a fiber-optic glucose biosensor | |
Preininger et al. | Optical fiber sensor for biological oxygen demand | |
Tsai et al. | Simultaneous determination of pH, urea, acetylcholine and heavy metals using array-based enzymatic optical biosensor | |
Wolfbeis et al. | A new sensing material for optical oxygen measurement, with the indicator embedded in an aqueous phase | |
US20060121547A1 (en) | Diffusion layer for an enzyme-based sensor application | |
Wolfbeis et al. | Reversible optical sensor membrane for hydrogen peroxide using an immobilized fluorescent probe, and its application to a glucose biosensor | |
CN100439513C (en) | Method and reagent system having a non-regenerative enzyme-coenzyme complex | |
EP1000171B1 (en) | Fluorescent polymeric sensor for the detection of urea | |
Tian et al. | Dually fluorescent sensing of pH and dissolved oxygen using a membrane made from polymerizable sensing monomers | |
US20010012539A1 (en) | Methods for producing optical sensors with reflective materials | |
EP1742039A1 (en) | Method for the determination of the concentration of a non-volatile analyte | |
Abel et al. | Fast responsive, optical trace level ammonia sensor for environmental monitoring | |
JP2001512236A (en) | Method and apparatus for normalizing fluorescence intensity signal | |
US5958786A (en) | Fluorescent polymeric sensor for the detection of creatinine | |
Neubauer et al. | Fibre-optic glucose biosensor using enzyme membranes with 2-D crystalline structure | |
US20040171094A1 (en) | Oxygen sensors disposed on a microtiter plate | |
JP2004517321A (en) | Sensor for optical emission measurement of analytes | |
Posch et al. | Optical sensor for hydrogen peroxide | |
Koncki et al. | Optical chemical sensing based on thin films of Prussian Blue | |
EP1496126B1 (en) | Nanoparticles for optical sensors | |
Guo et al. | A novel sensor based on the porous plastic probe for determination of dissolved oxygen in seawater | |
de Marcos et al. | Characterization of a urea optical sensor based on polypyrrole | |
EP0916091B1 (en) | Light-sensitive compositions for oxygen optrodes | |
Huber et al. | Serum chloride optical sensors based on dynamic quenching of the fluorescence of photo-immobilized lucigenin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1999936915 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2340983 Country of ref document: CA Ref country code: CA Ref document number: 2340983 Kind code of ref document: A Format of ref document f/p: F |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1999936915 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999936915 Country of ref document: EP |